Donate to Science & Enterprise

S&E on Mastodon

S&E on LinkedIn

S&E on Flipboard

Please share Science & Enterprise

$101M Challenge Seeks Healthy Aging Solutions

Aging couple, on a bench and in a wheelchair

A new challenge competition from XPrize calls for proactive and accessible health care solutions for improving the quality of life among older people worldwide. . . . → Read More: $101M Challenge Seeks Healthy Aging Solutions

Infographic: A.I. Getting Hype, But Fewer Venture Funds

Bar chart: Venture funding in artificial intelligence by quarter, 2019 to 2023

According to CB Insights, venture investments in A.I. are declining each quarter in 2023, with the number of venture deals reaching a low level not seen since 2017. . . . → Read More: Infographic: A.I. Getting Hype, But Fewer Venture Funds

Lab-Grown Tissue Company Gains $38M in Seed Funds

Andrei Georgescu and Dan Huh in the lab

A company producing tissue samples in the lab, for drug discovery and preclinical research with robotics and artificial intelligence, raised $38 million in seed funding. . . . → Read More: Lab-Grown Tissue Company Gains $38M in Seed Funds

Challenge Seeks Precise Addiction Strategies, Biomarkers, Treatments

Heroin abuse illustration

A challenge competition with a $50 million purse seeks new strategies to attack the global substance abuse epidemic, including personalized diagnostics and treatments. . . . → Read More: Challenge Seeks Precise Addiction Strategies, Biomarkers, Treatments

Start-Up Developing Precision Antibiotics for Resistant Bacteria

Pseudomonas Aeruginosa bacteria

A company formed earlier this year is developing precision treatments for bacteria resistant to conventional antibiotics, and raising £4.3 million ($US 5.4 million) in seed funds. . . . → Read More: Start-Up Developing Precision Antibiotics for Resistant Bacteria

Antibody/Gene Therapy Biotech Gains $138 Million in Early Funds

Adeno-associated virus

A developer of synthetic antibodies for neurodegenerative disorders delivered like gene therapies is raising €129 million ($US 138 million) in its first venture funding round. . . . → Read More: Antibody/Gene Therapy Biotech Gains $138 Million in Early Funds

Infographic – Digital Health Funding Continues Slide

Bar chart: Digital health venture funding by quarter, 2019 through 2023

Venture funding for digital health start-ups continued heading down in the third quarter of 2023, reaching low levels not seen in almost a decade. . . . → Read More: Infographic – Digital Health Funding Continues Slide

Challenge Seeks Transformative Human/A.I. Research Tech

Illustration: Artificial intelligence with a human face

A new challenge competition with $1 million in prizes seeks novel techniques for conducting biomedical research with data on human physiology and artificial intelligence. . . . → Read More: Challenge Seeks Transformative Human/A.I. Research Tech

Life Science Incubator Gains $100M in Start-Up Funds

Raven in a tree

A new-business accelerator program, begun earlier this year to advance and commercialize biomedical research discoveries from academic labs, is receiving a $100 million founding grant. . . . → Read More: Life Science Incubator Gains $100M in Start-Up Funds

Merger to Form Programmable Nano-Medicines Company

Molecule model in an open hand

A life science venture investor is merging two of its biotechnology portfolio companies to form a single developer of nanoscale medications with programmable properties. . . . → Read More: Merger to Form Programmable Nano-Medicines Company